BILL ANALYSIS �
AB 2369
Page 1
Date of Hearing: May 9, 2012
ASSEMBLY COMMITTEE ON APPROPRIATIONS
Felipe Fuentes, Chair
AB 2369 (Valadao) - As Introduced: February 24, 2012
Policy Committee: HealthVote:19-0
Business and Professions Vote: 6-0
Urgency: No State Mandated Local Program:
No Reimbursable: No
SUMMARY
This bill changes an authorization that allows the Department of
Corrections and Rehabilitation (CDCR) to require the use of
generic medications in their pharmacy services program when
available (with certain exemptions), to a requirement.
FISCAL EFFECT
Negligible state fiscal effect.
COMMENTS
1)Rationale . According to the author, as management of prison
health care services transitions from the control of the
federal Receiver and back to the jurisdiction of CDCR, it is
critical that fiscal responsibility is maintained while
upholding quality patient care. The author states that
generic medications are an excellent way to maintain fiscal
responsibility.
2)Background . AB 1628 (Committee on Budget), Chapter 729,
Statutes of 2010, was a Budget Trailer Bill that, among other
things, authorized CDCR to maintain a comprehensive pharmacy
services program for state prisons, and authorized CDCR to
incorporate various elements into its comprehensive pharmacy
services program, including a requirement for the use of
generic medications, when available, unless an exception is
reviewed and approved in accordance with an established
non-formulary approval process. This bill, instead of just
authorizing CDCR to incorporate a requirement for the use of
generic medications when available, requires the pharmacy
AB 2369
Page 2
program to use generic medications.
3)Current Practice . Existing policy of the California
Correctional Health Care Services (CCHCS) (federal Receiver)
mirrors the provisions of this bill. It states, "Equivalent
generic medication will be substituted for brand name
medications, unless otherwise specified by CCHCS pharmacy
policy. Requests for the use of brand name medication only
will be considered as formulary exceptions and should follow
the non-formulary approval process." Thus, this bill is not
expected to have a measurable impact. An LAO handout
assessing the Governor's 2012-13 budget proposal to augment
the budget for inmate pharmaceutical costs pinpoints great
variation in prescribing and exception approval practices
between prisons as a key cost driver for non-formulary drugs.
Analysis Prepared by : Lisa Murawski / APPR. / (916) 319-2081